Literature DB >> 17469038

Human islet isolation: semi-automated and manual methods.

Michelle Paget1, Hilary Murray, Clifford J Bailey, Richard Downing.   

Abstract

Large yields of high-viability human islets are necessary to service the expanding programmes of islet transplantation worldwide; similarly, there is an increasing demand from diabetes researchers for a reliable and cost-effective supply of human islets. The two main isolation methods are semi-automated and manual. Both methods rely on prompt and careful removal and transfer of the donor pancreas to allow isolation to commence, preferably within eight hours. Each method involves exocrine digestion with high-activity collagenase (Liberase). The semi-automated method is standardised, generally provides higher islet yields and is used for clinical transplant purposes, although it is not suitable for all donor pancreata. The manual method is less expensive and more adaptable and enables islets to be isolated for research from most donor pancreata.

Entities:  

Mesh:

Year:  2007        PMID: 17469038     DOI: 10.3132/dvdr.2007.010

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  3 in total

1.  Simplified method to isolate highly pure canine pancreatic islets.

Authors:  Orison O Woolcott; Richard N Bergman; Joyce M Richey; Erlinda L Kirkman; L Nicole Harrison; Viorica Ionut; Maya Lottati; Dan Zheng; Isabel R Hsu; Darko Stefanovski; Morvarid Kabir; Stella P Kim; Karyn J Catalano; Jenny D Chiu; Robert H Chow
Journal:  Pancreas       Date:  2012-01       Impact factor: 3.327

2.  Sustained insulin secretory response in human islets co-cultured with pancreatic duct-derived epithelial cells within a rotational cell culture system.

Authors:  H E Murray; M B Paget; C J Bailey; R Downing
Journal:  Diabetologia       Date:  2009-01-08       Impact factor: 10.122

3.  Real-time noninvasive assessment of pancreatic ATP levels during cold preservation.

Authors:  W E Scott; S Matsumoto; T Tanaka; E S Avgoustiniatos; M L Graham; P C Williams; L A Tempelman; D E Sutherland; B J Hering; B E Hammer; K K Papas
Journal:  Transplant Proc       Date:  2008-03       Impact factor: 1.066

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.